Particulate Matters: Categorizations, Considerations, and Compendia

Published on: 

Webcasts

Webinar Date/Time: Wed, Mar 6, 2024 10:00 AM EST

For anyone involved in packaging injectable drug products, understanding and addressing particulate matter is of utmost importance. Join us for a webinar that will delve deep into the world of particulate categorizations, considerations, and compendia, ensuring alignment with relevant regulatory bodies.

Register Free: https://www.pharmtech.com/pt_w/particulate-matters

Event Overview:

Particulate matter, as defined by the USP, refers to the presence of mobile undissolved particles in solutions, excluding gas bubbles. It is a critical aspect to consider for those involved in packaging injectable drug products, requiring a thorough understanding, mitigation, and adherence to regulatory standards. During this exclusive webinar, experts will delve into the fundamental aspects of categorizing, considering, and complying with particulate matter.


Key Learning Objectives:

  • Understand the various categories of particulate and how they are classified and monitored by regulatory authorities
  • Understand the risks and challenges injectable drug developers and their packaging suppliers must consider regarding particulate
  • Learn best practices for how to mitigate particulate in pharmaceutical packaging manufacturing and supply


Who Should Attend:

  • Quality/regulatory personnel in parenteral drug delivery
  • Formulation scientists and packaging engineers
  • Device development engineers and managers
  • Technical functions surrounding drug delivery systems
  • Extractable and leachable experts
  • Procurement professionals


Speaker:

Gabrielle Gehron
Technical & Scientific Expert
Datwyler

Gabrielle Gehron attended college at Widener University. In that time, she earned both a Bachelor’s and Master’s degree in Biomedical Engineering, graduating with honors. In May of 2019, she entered the pharmaceutical packaging industry in a technical, customer-facing role, recommending and evaluating packaging components for major drug companies.
Since then, Gabrielle has worked in multiple customer-facing technical roles at two of the leading pharmaceutical packaging companies in the world. Through COVID-19 and the aftermath, she has supported major biologics, generics, and pharma companies to provide high-quality products to their patients. Gabrielle currently serves as a Technical and Scientific Expert on Datwyler's Technical and Scientific Support team.

Register Free: https://www.pharmtech.com/pt_w/particulate-matters